Morgan Stanley’s Humanigen HGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding HGEN
Morgan Stanley's HGEN Position: Q3 2023 in Review
Morgan Stanley sold out of Humanigen (HGEN) in Q3 2023, closing a stake of 62,003 shares — an estimated $9.45K sold.
Morgan Stanley first reported a position in HGEN in Q3 2020 and held it in 12 quarters. The position peaked at $2.24M in Q2 2021. 3 funds tracked by Wall St. Rank hold HGEN as of Q3 2023.
- Morgan Stanley reported no remaining Humanigen position as of Q3 2023 after selling out during the quarter.
- Morgan Stanley sold 62,003 Humanigen shares in Q3 2023, an estimated $9.45K.
- Morgan Stanley first reported a position in Humanigen in Q3 2020 and held it in 12 quarters.
- Morgan Stanley's Humanigen position peaked at $2.24M in Q2 2021.
- 3 funds tracked by Wall St. Rank held Humanigen as of Q3 2023.
Based on Morgan Stanley's 13F filing for Q3 2023, filed 15 Nov 2023.